Mark Verratti
Vermogen: 4 M $ op 30-06-2026
Vermogen: 4 M $ op 30-06-2026
Mark Steven Verratti is currently Managing Director at Myriad Genetics GmbH and Chief Operating Officer at Myriad Genetics, Inc. Former positions include Vice President-Sales at LivaNova USA, Inc. from 2005 to 2012, and SVP, Chief Sales & Business Development Officer at Assurex Health, Inc. Education includes undergraduate studies at The Pennsylvania State University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-04-2026 | 629.646 ( 0,67% ) | 4 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MYRIAD GENETICS, INC. | Operationeel Directeur | 30-04-2025 |
Myriad Genetics GmbH
Myriad Genetics GmbH Pharmaceuticals: MajorHealth Technology Develops therapeutic and predictive medicine products | Algemeen Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology Operates as a personalized medicine company | President | - |
| CYBERONICS, INC. | Verkoop & Marketing | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
LivaNova USA, Inc.
LivaNova USA, Inc. Medical SpecialtiesHealth Technology Engages in design, development, sale and marketing of implantable medical devices | Health Technology |
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology Operates as a personalized medicine company | Health Technology |
Myriad Genetics GmbH
Myriad Genetics GmbH Pharmaceuticals: MajorHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau